Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Metronidazole 500mg suppositories
0501110C0AAAGAG
|
Metronidazole (Systemic) | Metronidazole | Infections | 122 |
|
Mefloquine 250mg tablets
0504010L0AAAAAA
|
Mefloquine hydrochloride | Mefloquine hydrochloride | Infections | 121 |
|
Clindamycin 75mg/5ml oral suspension
0501060D0AAANAN
|
Clindamycin hydrochloride (Systemic) | Clindamycin hydrochloride | Infections | 120 |
|
Rifampicin 300mg / Isoniazid 150mg tablets
0501090S0AAABAB
|
Rifampicin/isoniazid | Rifampicin combined preparations | Infections | 114 |
|
Tinidazole 500mg tablets
0501110G0AAABAB
|
Tinidazole | Tinidazole | Infections | 110 |
|
Tobramycin 80mg/2ml solution for injection vials
0501040U0AAACAC
|
Tobramycin (Systemic) | Tobramycin | Infections | 109 |
|
Zovirax 200mg dispersible tablets
0503021C0BBAGAG
|
Zovirax (Systemic) | Aciclovir | Infections | 108 |
|
Vermox 100mg/5ml oral suspension
0505010D0BBABAA
|
Vermox | Mebendazole | Infections | 107 |
|
Posaconazole 100mg gastro-resistant tablets
0502010A0AAABAB
|
Posaconazole | Posaconazole | Infections | 102 |
|
Albendazole 400mg tablets
0505030A0AAADAD
|
Albendazole | Albendazole | Infections | 101 |
|
Valganciclovir 450mg tablets
0503022B0AAAAAA
|
Valganciclovir hydrochloride | Valganciclovir hydrochloride | Infections | 101 |
|
Cefaclor 125mg/5ml oral suspension
0501021A0AAABAB
|
Cefaclor | Cefaclor | Infections | 100 |
|
Doxycycline 50mg/5ml oral suspension
0501030I0AAAMAM
|
Doxycycline hyclate (Antibacterial) | Doxycycline hyclate | Infections | 100 |
|
Nitrofurantoin 50mg/5ml oral liquid
0501130R0AAANAN
|
Nitrofurantoin | Nitrofurantoin | Infections | 99 |
|
Clindamycin 75mg capsules
0501060D0AAAAAA
|
Clindamycin hydrochloride (Systemic) | Clindamycin hydrochloride | Infections | 96 |
|
Proguanil 100mg / Atovaquone 250mg tablets
0504010U0AAAAAA
|
Proguanil hydrochloride/atovaquone | Proguanil hydrochloride with atovaquone | Infections | 96 |
|
Rifabutin 150mg capsules
0501090Q0AAABAB
|
Rifabutin | Rifabutin | Infections | 95 |
|
Lamisil 250mg tablets
0502050C0BBAAAA
|
Lamisil (Systemic) | Terbinafine hydrochloride | Infections | 93 |
|
Demeclocycline 300mg capsules
0501030F0AAAJAJ
|
Demeclocycline hydrochloride | Demeclocycline hydrochloride | Infections | 91 |
|
Augmentin 250/62 oral suspension
0501013K0BBANAI
|
Augmentin | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 89 |
|
Oseltamivir 6mg/ml oral suspension sugar free
0503040B0AAAGAG
|
Oseltamivir phosphate | Oseltamivir phosphate | Infections | 86 |
|
Griseofulvin 125mg tablets
0502050B0AAABAB
|
Griseofulvin (Systemic) | Griseofulvin | Infections | 84 |
|
Voriconazole 200mg tablets
0502010D0AAAAAA
|
Voriconazole | Voriconazole | Infections | 83 |
|
Tobramycin 300mg/5ml nebuliser liquid ampoules
0501040U0AAAGAG
|
Tobramycin (Systemic) | Tobramycin | Infections | 81 |
|
Vermox 100mg chewable tablets
0505010D0BBAAAD
|
Vermox | Mebendazole | Infections | 79 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.